FDA reform should be among first issues considered in 1997, Rep. Barton says.
This article was originally published in The Tan Sheet
Executive Summary
FDA REFORM MARKUP IN COMMERCE COMMITTEE STILL LONG-SHOT POSSIBILITY before Congress adjourns at the end of September, Rep. Joe Barton (R-Tex.) said Sept. 16 at the National Electrical Manufacturers Association's Diagnostic Imaging and Therapy Systems Division annual meeting in Seattle. "I'm going to try at least one time" before the current session is over "to get [Commerce Committee] Chairman [Thomas] Bliley [R-Va.] to mark up" the medical device (HR 3201), drug (HR 3199) and food reform (HR 3200) bills, Barton said.